Genetron Holdings Analysis
Genetron Holdings is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Genetron Holdings delisted stock analysis is to determine its intrinsic value, which is an estimate of what Genetron Holdings is worth, separate from its market price. There are two main types of Genetron Holdings' stock analysis: fundamental analysis and technical analysis.
The Genetron Holdings stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Genetron Holdings' ongoing operational relationships across important fundamental and technical indicators.
Genetron |
Genetron Stock Analysis Notes
The company has price-to-book (P/B) ratio of 1.68. Some equities with similar Price to Book (P/B) outperform the market in the long run. Genetron Holdings recorded a loss per share of 3.62. The entity had not issued any dividends in recent years. The firm had 1:3 split on the 26th of October 2023. Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. Genetron Holdings Limited was founded in 2015 and is headquartered in Beijing, the Peoples Republic of China. Genetron Holdings operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1154 people. To learn more about Genetron Holdings call Sizhen Wang at 86 10 5090 7500 or check out https://www.genetronhealth.com.Genetron Holdings Investment Alerts
| Genetron Holdings is not yet fully synchronised with the market data | |
| Genetron Holdings has some characteristics of a very speculative penny stock | |
| Genetron Holdings has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 650.71 M. Reported Net Loss for the year was (810.63 M) with profit before taxes, overhead, and interest of 337.97 M. | |
| Genetron Holdings has about 472.68 M in cash with (460.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.1. |
Genetron Holdings Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Genetron Holdings previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 10th of May 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Genetron Market Capitalization
The company currently falls under 'Small-Cap' category with a total capitalization of 127.29 M.Genetron Profitablity
The company has Net Profit Margin of (1.24) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.87) %, which entails that for every $100 of revenue, it lost $0.87.Genetron Holdings Outstanding Bonds
Genetron Holdings issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Genetron Holdings uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Genetron bonds can be classified according to their maturity, which is the date when Genetron Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Genesis Energy 775 Corp BondUS37185LAL62 | View | |
| GEL 8875 15 APR 30 Corp BondUS37185LAN29 | View | |
| US37185LAM46 Corp BondUS37185LAM46 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Genetron Holdings to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Genetron Stock
If you are still planning to invest in Genetron Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genetron Holdings' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |